NCT02735083Not yet recruitingPhase 3
A study to evaluate the long-term safety of patients with advanced lymphoid malignancies who have been previously administered with UCART19
Long-term follow-up study of patients who have previously been exposed to UCART19 (allogeneic engineered T-cells expressing a lentiviral-based anti-CD19 chimeric antigen receptor)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 16 Sept 2026
Brief summary (registry, in English)
To evaluate the long-term safety of patients with advanced lymphoid leukemia who have been previously administered with UCART19.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 1 (estimated)
- First submitted
- 3 Apr 2026
- Start date
- 3 Apr 2026
- Lead sponsor
- Institut De Recherches Internationales Servier IRIS
- Diseases
- Childhood cancers
- NCT number
- NCT02735083
- EU CT number
- 2026-526212-37-00
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 1
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Other
- No exclusion criteria for this study.
Who the study is looking for
- Written informed consent obtained prior any study-specific procedure (patient or parent(s) or legal representative).
- Patient dosed with UCART19 who completed or discontinued early from a sponsored or from any investigator-initiated study that tested UCART19, or patients who were administered UCART19 under a special access scheme (compassionate use).
- Female patients of childbearing potential and male patients with partners of childbearing potential must continue to use an effective method of birth control as well as their partners for a 12-month duration after the last UCART19 administration.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hopital Saint Antoine Coordinator of this site? Confirm its status | Paris Cedex 12 | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.